X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195,095 | 216,908 | 217,049 | 69,632 | 39,220 |
| Marketable Securities | 12,874 | 16,812 | 35,949 | 52,562 | 23,731 |
| Receivables | 2,047 | 1,113 | 573 | 1,606 | 1,865 |
| Inventories | 5,502 | 4,637 | 4,479 | 4,080 | 3,170 |
| TOTAL | $218,855 | $241,982 | $261,577 | $132,805 | $72,942 |
| Non-Current Assets | |||||
| PPE Net | 111 | 146 | 182 | 218 | 254 |
| Intangibles | 30,452 | 26,414 | 26,601 | 26,789 | 26,976 |
| Other Non-Current Assets | 3,645 | 1,739 | 2,101 | 3,743 | 4,996 |
| TOTAL | $34,208 | $28,299 | $28,884 | $30,750 | $32,226 |
| Total Assets | $253,063 | $270,281 | $290,461 | $163,555 | $105,168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,934 | 5,073 | 5,696 | 5,053 | 7,709 |
| Accrued Expenses | 14,125 | 17,055 | 18,603 | 16,661 | 13,065 |
| TOTAL | $19,366 | $23,771 | $25,757 | $23,506 | $22,896 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,759 | 76,520 | 76,291 | 76,062 | 75,841 |
| Deferred Revenues | 842 | 910 | 464 | 592 | 754 |
| Other Non-Current Liabilities | 892 | 1,423 | 1,502 | 1,579 | 1,633 |
| TOTAL | $78,243 | $78,060 | $78,414 | $78,430 | $78,301 |
| Total Liabilities | $97,609 | $101,831 | $104,171 | $101,936 | $101,197 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,147 | 94,320 | 90,920 | 87,437 | 11,408 |
| Common Shares | 96 | 94 | 91 | 25 | 8 |
| Retained earnings | -630,952 | -614,795 | -594,554 | -570,629 | -540,814 |
| Other shareholders' equity | -123 | -122 | -109 | -118 | -138 |
| TOTAL | $155,454 | $168,450 | $186,290 | $61,619 | $3,971 |
| Total Liabilities And Equity | $253,063 | $270,281 | $290,461 | $163,555 | $105,168 |